Jupiter Topco LLC Makes New Investment in Ralliant Corporation $RAL

Jupiter Topco LLC bought a new position in Ralliant Corporation (NYSE:RAL) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 48,700 shares of the company’s stock, valued at approximately $3,588,000.

A number of other institutional investors have also made changes to their positions in the company. Allworth Financial LP lifted its stake in Ralliant by 134.4% during the fourth quarter. Allworth Financial LP now owns 511 shares of the company’s stock worth $26,000 after purchasing an additional 293 shares during the last quarter. Rothschild Investment LLC raised its holdings in shares of Ralliant by 98.1% during the fourth quarter. Rothschild Investment LLC now owns 612 shares of the company’s stock worth $31,000 after purchasing an additional 303 shares during the period. UMB Bank n.a. lifted its position in shares of Ralliant by 49.6% in the 4th quarter. UMB Bank n.a. now owns 983 shares of the company’s stock worth $50,000 after buying an additional 326 shares during the last quarter. Maryland State Retirement & Pension System lifted its position in shares of Ralliant by 1.5% in the 4th quarter. Maryland State Retirement & Pension System now owns 21,940 shares of the company’s stock worth $1,117,000 after buying an additional 329 shares during the last quarter. Finally, Dunhill Financial LLC acquired a new position in shares of Ralliant in the 2nd quarter valued at about $25,000.

Insider Buying and Selling

In related news, SVP Karen M. Bick sold 6,062 shares of the stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $72.00, for a total value of $436,464.00. Following the completion of the transaction, the senior vice president directly owned 31,668 shares of the company’s stock, valued at $2,280,096. This represents a 16.07% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Tamara S. Newcombe sold 12,936 shares of the firm’s stock in a transaction that occurred on Friday, August 14th. The shares were sold at an average price of $71.79, for a total value of $928,675.44. Following the completion of the sale, the chief executive officer owned 251,967 shares in the company, valued at approximately $18,088,710.93. This represents a 4.88% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.42% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the stock. Citigroup boosted their price objective on shares of Ralliant from $81.00 to $82.00 and gave the company a “buy” rating in a research report on Friday, July 31st. Morgan Stanley raised their target price on shares of Ralliant from $68.00 to $85.00 and gave the stock an “overweight” rating in a report on Tuesday, June 23rd. Wall Street Zen downgraded Ralliant from a “strong-buy” rating to a “buy” rating in a research note on Sunday. Barclays upped their target price on Ralliant from $52.00 to $67.00 and gave the company an “overweight” rating in a report on Wednesday, May 13th. Finally, Zacks Research raised Ralliant from a “hold” rating to a “strong-buy” rating in a report on Tuesday, June 30th. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $75.70.

Ralliant Stock Down 1.1%

Ralliant stock opened at $61.06 on Wednesday. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.00 and a current ratio of 1.52. Ralliant Corporation has a one year low of $37.27 and a one year high of $75.41. The company has a 50-day simple moving average of $68.12 and a 200-day simple moving average of $56.79. The firm has a market capitalization of $6.76 billion, a P/E ratio of -5.63, a P/E/G ratio of 2.29 and a beta of 1.54.

Ralliant (NYSE:RAL) last issued its quarterly earnings data on Thursday, July 30th. The company reported $0.68 earnings per share for the quarter, beating the consensus estimate of $0.63 by $0.05. The firm had revenue of $567.80 million for the quarter. Ralliant had a negative net margin of 56.38% and a positive return on equity of 14.97%. Ralliant has set its FY 2026 guidance at 2.760-2.900 EPS and its Q3 2026 guidance at 0.720-0.780 EPS. As a group, equities analysts expect that Ralliant Corporation will post 2.87 earnings per share for the current year.

Ralliant Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be issued a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date of this dividend is Tuesday, September 8th. Ralliant’s payout ratio is -1.84%.

Ralliant Company Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.